Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Macitentan

EU orphan designation number: EU/3/09/707   
Active ingredient: Macitentan
Indication: Treatment of idiopathic pulmonary fibrosis
Sponsor: Actelion Registration Ltd
Cheswick Tower, 13th floor, 389 Cheswick High Road, London W4 4AL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2010 Centralised Orphan - Designation EMEA/OD/104/09 (2010)653 of 28/01/2010
02/07/2014 Centralised Orphan - Change of address